PatientsVille.com Logo

PROSTATE CANCER and Viagra

PatientsVille

PROSTATE CANCER Symptoms and Causes

The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is common among older men. It is rare in men younger than 40. Risk factors for developing prostate cancer include being over 65 years of age, family history, and being African-American.

Symptoms of prostate cancer may include

  • Problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling
  • Low back pain
  • Pain with ejaculation

To diagnose prostate cancer, you doctor may do a digital rectal exam to feel the prostate for lumps or anything unusual. You may also get a blood test for prostate-specific antigen (PSA). These tests are also used in prostate cancer screening, which looks for cancer before you have symptoms. If your results are abnormal, you may need more tests, such as an ultrasound, MRI, or biopsy.

Treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Men with prostate cancer have many treatment options. The treatment that's best for one man may not be best for another. The options include watchful waiting, surgery, radiation therapy, hormone therapy, and chemotherapy. You may have a combination of treatments.

NIH: National Cancer Institute

Check out the latest treatments for PROSTATE CANCER

PROSTATE CANCER treatment research studies

Viagra clinical trials, surveys and public health registries


Find Drug Side Effect reports



Viagra Side Effects

Headache (505)
Erection Increased (390)
Flushing (324)
Optic Ischaemic Neuropathy (314)
Erectile Dysfunction (300)
Vision Blurred (278)
Hypertension (219)
Dizziness (211)
Prostate Cancer (194)
Visual Acuity Reduced (189)
Nasal Congestion (184)
Incorrect Dose Administered (178)
Blood Cholesterol Increased (173)
Penis Disorder (172)
Death (168)
Myocardial Infarction (165)
Cyanopsia (160)
Dyspnoea (145)
Feeling Abnormal (141)
Cerebrovascular Accident (134)
Blood Pressure Increased (95)
Chest Pain (93)
Visual Field Defect (92)
Diabetes Mellitus (92)
Malaise (83)
Nausea (80)
Pain (78)
Penile Pain (77)
Cataract (75)
Loss Of Consciousness (73)
Heart Rate Increased (72)
Depression (71)
Tinnitus (70)
Condition Aggravated (69)
Off Label Use (68)
Feeling Hot (68)
Visual Impairment (67)
Abdominal Discomfort (66)
Anxiety (66)
Visual Disturbance (65)
Erythema (64)
Dyspepsia (64)
Fall (62)
Ejaculation Disorder (60)
Fatigue (60)
Coronary Artery Occlusion (58)
Weight Decreased (54)
Deafness (54)
Blood Testosterone Decreased (53)
Hypotension (53)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Blepharospasm.

I am 67 and I was precribed Diamicron MR 30mg capsules for two years, recently I was prescribed Proscar for prostate BPH then I developed severe eczema I stopped taking Proscar immediately and now I can not take diamicro MR any more because it give

<strong>I was put on Metoprolol ER 2 years ago after having cancer. I was </strong><span style='text-decoration: underline;'>tired all day could not sleep at night, had anxiety attacks, co

1 day off the start of week 3 from day one my dreams have been crazy intense colourful wonderuss things, not stopped smoking yet although i'm not enjoying the dreaded cancer sticks....................... joking aside i have this careless attitude

4 years old boy ,liver cancer ,liver transplant . Is going to start Sorafenib . Is there any kids that got this treatment ?

52years old went on kliovance 1mg, felt great on the tables no hot flushes no weight gain feeling pretty good.Now 53 l have lung cancer dont know if it is related or not,l have never smoked in my life.l had the cancer remove and hope for the best.but

A friend of mine has cancer and the doctors are talking about having surgery and removing the sciatica nerve. My question is will he be a function with this removal.

Afer five years of Famera treatment for breast cancer, I was anticipating feeling so much better. Now diagnosed with CFS and Fibromyalgia my doctor is trying to treat me lately with Chronic Behavorial Therapy. Yesterday my daughter took me to another

After taking raptiva for about 1.5 years i developed pancreatic cancer. Half of my pancreas and all of my spleen was removed as a result I now have dibetes

After taking vistaril 25mh capsules i suffered from urinary retention. So bad I had to be hospitalized. I previously have been treated for an enlarged prostate.

Age 58, stage 1 breast cancer a year ago. double mastecomy, by choice. chemo...started aromasin in October 2008. had a bone denstity test in September 2008 and started fosamax.... had another bone denstity test in April 2009 and before the results

PROSTATE CANCER Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?
Condition: Pulmonary Hypertension
Interventions: Drug: Sildenafil (Viagra);   Drug: Sildenafil;   Drug: Placebo
Outcome Measures: To determine the efficacy of 12.5mg oral sildenafil to decrease the mPAP in patients presenting with a mPAP >/= 25mmHg after cardiopulmonary bypass.;   To determine the efficacy of a second dose of oral sildenafil 12.5mg to decrease the mPAP in those patients who do not respond with a 20% decrease in mPAP after the initial administration of study medication.;   To determine the safety of oral sildenafil to treat increased mPAP after cardiac surgery.
2 Unknown  Sildenafil for Prevention of Cerebral Vasospasm
Conditions: Subarachnoid Hemorrhage;   Cerebral Vasospasm;   Rupture of Intracranial Aneurysm
Interventions: Drug: Placebo;   Drug: Sildenafil Citrate, 25 mg, 3 times a day.;   Drug: Sildenafil Citrate 50 mg, 3 times a day
Outcome Measures: New neurological Deficit;   Transcranial Ecodoppler;   Mortality;   Side effects;   Time to discharge;   Rankin Scale
3 Unknown  A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil Citrate 20mg Tablet Sublingual;   Drug: Viagra ® 50mg tablet Coated
Outcome Measures: Evaluate a possible superiority expressed by the faster onset of action.;   Evaluate the efficacy and tolerability of Sildenafil Citrate 20mg Sublingual tablet, compared to Viagra ® 50mg tablet Coated in control of Erectile Dysfunction.
4 Recruiting Pharmacokinetics of Sildenafil in Premature Infants
Condition: Persistent Pulmonary Hypertension of the Newborn
Intervention: Drug: 1 dose of sildenafil
Outcome Measures: Area under the plasma concentration versus time curve 0-24 hours for sildenafil;   Peak plasma concentration of sildenafil;   Clearance of sildenafil;   Volume of distribution at steady state;   Half life of sildenafil;   Number of subjects with adverse events as a measure of safety and tolerability.;   Correlation between serum and dried blood spot samples;   Evaluate P450 single nucleotide polymorphisms (SNPs)
5 Unknown  Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Sildenafil (Viagra);   Drug: Placebo
Outcome Measure: The principal aim of this study is to determine whether chronic fatigue syndrome (CFS) is due to inadequate blood flow to the brain and to test a medication, Viagra, which should help increase blood flow to the brain and improve the symptoms of CFS.
6 Unknown  Effects of Viagra on Heart Function in Patients With Heart Failure
Conditions: Heart Failure;   Left Ventricular Dysfunction
Intervention: Drug: sildenafil
Outcome Measures: The primary outcome measure is a fall in the left ventricular filling pressure in association with administration of sildenafil;   A secondary outcome is the distance walked with the 6-minute walk test after the administration of sildenafil
7 Not yet recruiting Effects of Oral Sildenafil on Mortality in Adults With PAH
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil citrate
Outcome Measures: Overall Survival (OS);   Time to first clinical worsening (TTCW) event;   6 Minute Walk Distance (6MWD) at Months 6 & 12
8 Recruiting VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension
Condition: Pulmonary Hypertension Associated With Connective Tissue Disease
Intervention: Drug: Sildenafil
Outcome Measures: efficacy of Sildenafil I.V. for vasoreactivity testing;   clinical efficacy of sildenafil per os predicted by testing it intravenously in the course of oral therapy
9 Unknown  Early Start of Oral Sildenafil 100mg for Erectile Dysfunction After Robotic Assisted Laparoscopic Radical Prostatectomy
Condition: Prostate Cancer
Intervention: Drug: sildenafil 100mg
Outcome Measures: patterns of recovery of erectile functions after nerve sparing RALP in men with on- demand sildenafil 100mg dosing from the early postoperative period (using IIEF-5);   comparison of the potency rates in men with on- demand sildenafil 100mg dosing from the early postoperative period with from the delayed postoperative period
10 Unknown  Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure
Condition: Heart Failure
Intervention: Drug: Sildenafil
Outcome Measures: Change in 6-minute walk distance;   Changes in peak oxygen consumption (measured by cardiopulmonary exercise testing);   Change in the level of neurohormones (b-type natriuretic peptide, catecholamines, ET-1),;   Change in quality of life
11 Unknown  The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation
Condition: Fontan Circulation
Interventions: Drug: sildenafil;   Other: placebo
Outcome Measure: An increase in exercise capacity for patients administered sildenafil
12 Recruiting The Revaki-001. A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery
Condition: Acute Kidney Injury
Intervention: Drug: Sildenafil
Outcome Measures: Area under the plasma concentration versus time curve and Plasma Concentration of Sildenafil;   Serum creatinine and Biochemical markers of AKI
13 Recruiting Effects of Sildenafil on Choroidal Thickness in AMD
Condition: Age-related Macular Degeneration
Intervention: Drug: Sildenafil citrate
Outcome Measures: Change in Choroidal Thickness as Assessed on Enhanced-Depth Imaging Optical Coherence Tomography (EDI-OCT);   Change in Central Foveal Thickness as assessed by optical coherence tomography (OCT)
14 Unknown  Viagra for the Treatment of IUGR
Condition: IUGR
Intervention: Drug: Viagra administration in IUGR/PET pregnancies
Outcome Measures: Uteroplacental perfusion;   Fetal growth;   Maternal and fetal safety
15 Not yet recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
Outcome Measures: Exercise Capacity;   Flow-Mediated Dilation (FMD);   Arterial Stiffness Evaluation (PWV);   Physio Flow
16 Recruiting "As Required" Oral Sildenafil in Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: Sildenafil 40 mg;   Drug: Sildenafil 80 mg;   Drug: Placebo
Outcome Measures: Mean change in the Raynaud's Condition Score (RCS) during treatment, as compared to placebo.;   Frequency of RP: number of RP attacks during treatment, as compared to placebo.;   Patients' preference: comparison between the number of patients favoring a treatment to another.;   Pain associated with RP: Mean change in the Raynaud's pain score during treatment, as compared to placebo.;   Frequency and severity of adverse drug events during treatment, as compared to placebo;   Microvascular reactivity: index of skin perfusion in response to local/regional cooling after a single dose of sildenafil, as compared to placebo (laboratory experiments)
17 Recruiting Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: Sildenafil 20mg oral vs Sildenafil 10mg intravenous
Outcome Measure: Effectiveness
18 Recruiting Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer
Condition: Kidney Tumor
Interventions: Drug: sildenafil citrate;   Other: placebo;   Procedure: therapeutic conventional surgery
Outcome Measures: Accrual rate;   Retention rate;   Participation rate;   Change in GFR;   Change in proteinuria;   Estimated blood loss;   Hemoglobin concentration;   Changes in blood pressure measurements;   Vasopressor support requirements during the operative procedure;   Intravenous fluid requirements during the operative procedure;   Overall complication rates;   Preliminary effect size of sildenafil citrate on change in GFR
19 Unknown  On Demand Versus Daily Sildenafil for Patients Undergoing Radical Prostatectomy
Condition: Erectile Dysfunction
Intervention: Drug: Sildenafil
Outcome Measures: Proportion of patients with an Erectile Function domain score of International Index of Erectile Function ( IIEF) => 22 at the end of the wash-out period (44 wks after surgery);   Proportion of patients with an Erectile Function domain score of IIEF => 22 at the end of the study (52 wks after surgery);   IIEF - Domain Scores for: Erection Hardness Score (1-4) Intercourse success rates defined by the Sexual Encounter Profile (SEP) questionnaire (questions 2 and 3) Safety Endpoints: Adverse event summarized Global assessment questions
20 Not yet recruiting Growth Hormone or Sildenafil as Therapies for Fatigue in Mild-​Traumatic-brain-injury (MTBI)
Condition: Traumatic Brain Injury
Interventions: Drug: Growth Hormone;   Drug: Sildenafil;   Drug: Placebo
Outcome Measures: Perceptual fatigue as measured weekly using the Brief Fatigue Inventory;   Performance fatigue as measured by using hand and leg dynamometry.